524661 — Welcure Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹988.75m
- IN₹986.59m
- 36
- 49
- 88
- 63
Annual balance sheet for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | — | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.053 | 0.475 | 0.66 | 0.012 | 0.216 |
Net Total Receivables | 0.193 | 0.255 | — | 0.002 | 0 |
Total Other Current Assets | |||||
Total Current Assets | 0.246 | 0.73 | 0.66 | 0.059 | 0.318 |
Net Property, Plant And Equipment | — | — | — | 0.568 | 0.209 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.246 | 0.73 | 0.968 | 15.3 | 13.7 |
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.103 | 0.036 | 0.038 | 0.136 | 0.306 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.103 | 0.036 | 0.038 | 0.136 | 0.306 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.143 | 0.694 | 0.93 | 15.2 | 13.4 |
Total Liabilities & Shareholders' Equity | 0.246 | 0.73 | 0.968 | 15.3 | 13.7 |
Total Common Shares Outstanding |